GENinCode (GENI) Competitors GBX 3.93 +0.13 (+3.32%) (As of 12/20/2024 05:46 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors GENI vs. EDR, DIS, AMC, LION, SPHR, GVC, SONG, NFC, MCS, and TKOShould you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Egdon Resources (EDR), Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Hipgnosis Songs (SONG), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Taseko Mines (TKO). These companies are all part of the "entertainment" industry. GENinCode vs. Egdon Resources Distil Amur Minerals Lionsgold Sphere Medical Entain PLC (GVC.L) Hipgnosis Songs Next Fifteen Communications Group McCarthy & Stone Taseko Mines GENinCode (LON:GENI) and Egdon Resources (LON:EDR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Does the MarketBeat Community favor GENI or EDR? Egdon Resources received 368 more outperform votes than GENinCode when rated by MarketBeat users. CompanyUnderperformOutperformGENinCodeN/AN/AEgdon ResourcesOutperform Votes36882.51% Underperform Votes7817.49% Is GENI or EDR more profitable? Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -228.70%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets GENinCode-228.70% -156.92% -63.99% Egdon Resources 31.06%8.26%4.22% Does the media refer more to GENI or EDR? In the previous week, GENinCode's average media sentiment score of 0.00 equaled Egdon Resources'average media sentiment score. Company Overall Sentiment GENinCode Neutral Egdon Resources Neutral Which has more volatility & risk, GENI or EDR? GENinCode has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Egdon Resources has a beta of -0.25, suggesting that its share price is 125% less volatile than the S&P 500. Do institutionals and insiders believe in GENI or EDR? 47.6% of GENinCode shares are owned by institutional investors. Comparatively, 18.6% of Egdon Resources shares are owned by institutional investors. 39.8% of GENinCode shares are owned by insiders. Comparatively, 63.8% of Egdon Resources shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation and earnings, GENI or EDR? Egdon Resources has higher revenue and earnings than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGENinCode£2.60M2.67-£5.94M-£0.05-78.52Egdon Resources£8.08M0.00£2.51MN/AN/A SummaryEgdon Resources beats GENinCode on 8 of the 10 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get GENinCode News Delivered to You Automatically Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart GENI vs. The Competition Export to ExcelMetricGENinCodeDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£6.95M£27.75M£5.14B£1.88BDividend YieldN/A5.44%5.09%5.54%P/E Ratio-78.522.0090.051,810.29Price / Sales2.672,398.621,117.14382,807.21Price / Cash0.8311.4243.0428.42Price / Book1.963.044.782.91Net Income-£5.94M£53.40M£120.31M£156.83M7 Day PerformanceN/A-3.11%-1.92%-1.92%1 Month Performance-6.08%-0.11%11.51%17.93%1 Year Performance-30.20%-14.32%30.61%29.50% GENinCode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENIGENinCodeN/AGBX 3.93+3.3%N/A-30.2%£6.95M£2.60M-78.522,300Gap UpEDREgdon ResourcesN/AGBX 4.40flatN/AN/A£24.88M£8.08M220.0011,000DISDistilN/AN/AN/A-80.9%£1.29M£1.52M17.50220,000Gap DownHigh Trading VolumeAMCAmur MineralsN/AGBX 0.09flatN/AN/A£1.25MN/A-8.7533,700LIONLionsgoldN/AN/AN/AN/A£0.00N/A0.002,021SPHRSphere MedicalN/AN/AN/AN/A£0.00N/A0.0010,900Gap UpHigh Trading VolumeGVCEntain PLC (GVC.L)N/AN/AN/A+0.0%£6.08B£3.40B-38.7913,345SONGHipgnosis SongsN/AGBX 101.80flatN/AN/A£1.23B£124.41M-1,131.111NFCNext Fifteen Communications GroupN/AGBX 799-3.0%N/AN/A£787.02M£602.53M-974.3912,800Gap UpMCSMcCarthy & StoneN/AGBX 119.80flatN/AN/A£644.25M£621.43M21.397,500High Trading VolumeTKOTaseko Mines1.5056 of 5 starsGBX 159-3.6%GBX 275+73.0%+43.9%£466.43M£582.21M1,590.00N/ANews CoverageGap Down Related Companies and Tools Related Companies EDR Competitors DIS Competitors AMC Competitors LION Competitors SPHR Competitors GVC Competitors SONG Competitors NFC Competitors MCS Competitors TKO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:GENI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENI Stock Alerts